Research Focus
Advancing ALS and neurodegeneration through genetics and clinical insights
Our Research
Focused on neurodegeneration research and clinical translation.
Neurogenetics Lab
Studying TDP-43 and molecular genetics in ALS.
Cell Culture Facility
iPSC models for drug screening and disease modeling.
Clinical Research
Biobank management and patient data integration.
Units
Four cores driving ALS research and clinical progress
Neurogenetics Lab
Decoding genetic factors behind ALS and neurodegeneration
Cell Culture
Growing patient-derived stem cells for disease modeling
Clinical Unit
Linking lab discoveries with patient care and biobank samples
Bioinformatics
Transforming data into insights for targeted therapies
→
→
→
→
Gallery
Snapshots from our labs and research breakthroughs
FAQs
What is TDP-43?
TDP-43 is a protein involved in neurodegenerative diseases like ALS, studied through molecular genetics.
How do iPSCs help research?
What is the clinical research unit?
How does AI support your work?
What assistive devices do you develop?
Induced pluripotent stem cells let us model patient neurons in the lab for drug screening.
Our clinical unit collects patient data and samples, supporting translation from lab findings to therapies.
AI helps analyze biomarkers remotely and accelerates data processing within our digital ecosystem.
We engineer devices to support mobility and communication for neurodegenerative patients.
Get in Touch
Reach out for collaboration or questions anytime.
